DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Mandarin Oriental, Singapore

2018 年 01 月 29 日 8:00 上午 - 2018 年 01 月 30 日 5:00 下午

5 Raffles Ave, , Marina Square,, Singapore 039797, Singapore

Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases

概览

DIA and the Duke-NUS Centre of Regulatory Excellence (CoRE) will host a 2-day conference in Singapore on accelerating access to health products to improve the response to pandemic diseases. Over these 2 days, we will discuss the global impact of infectious diseases and approaches to expedite research and product development (including vaccines and medical devices). We will also explore the pathways to accelerate patient access to innovative products and how to effectively manage a pandemic situation in Asia. Speakers will include experts from Health Authorities, NGOs, as well as the industry and academia.

Download Registration Form

Download the Exhibitor/Sponsorship Prospectus

Just in!

Dorothee Grimald, PharmD, Director of Global Regulatory Policy for MSD International in Singapore, and Chair for this conference, discusses ways to expedite patient access to combatic therapies in a late-breaking interview. Listen now!

 

Featured

Want to learn more about Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases? You've come to the right site!

谁应该参加?

  • Industry professionals involved in Research & Development, Regulatory Affairs and Medical Affairs in Pharmaceuticals and Medical Technology
  • Regulators and personnel from Health Authorities and Ministries
  • Academia and Researchers

    项目委员会

    • Dorothee  Grimald, PharmD
      Dorothee Grimald, PharmD Director, Global Regulatory Policy
      Merck Sharp & Dohme (MSD), Germany
    • James  Leong, PhD, MPharm
      James Leong, PhD, MPharm Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
      Duke NUS Medical School, Singapore
    • Esther Siu-Suet Chu, MBA
      Esther Siu-Suet Chu, MBA Head/ Executive Director, Drug Development Operations (APAC)
      Allergan Singapore Pte Ltd, Singapore
    • Finny  Liu, MSc, RPh
      Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
      Roche, Singapore
    • Michelle  Cheng, RPh, RAC
      Michelle Cheng, RPh, RAC Head of Regulatory Affairs, Singapore & Asian Emerging Markets
      Novartis Singapore Pte Ltd, Singapore
    • Thean Soo  Lo
      Thean Soo Lo
      Regulatory Affairs Management Consultant, Singapore
    • Silke  Vogel, PhD
      Silke Vogel, PhD Deputy Director, Center of Regulatory Excellence (CoRE); Associate Dean
      Duke NUS , Singapore
    • Shun  Jin, MBA
      Shun Jin, MBA Head, Regulatory Affairs, APMA
      Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
    • Jing Ping  Yeo, PhD
      Jing Ping Yeo, PhD Head - Transformation
      George Clinical, Singapore
    • Kum Cheun  Wong, PharmD
      Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
      Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
    • Stephanie  Danandjaja
      Stephanie Danandjaja APAC Medical Director
      Abbott EPD, Singapore
    • Fengyun(Vicky)  Han
      Fengyun(Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
      Johnson & Johnson Pte. Ltd., Singapore

    Digital Learning Catalog

    DIA Learning: eLearning Soultions
    Download

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。